Author: Admin

Looking So Good Doesn’t Have To Hurt So Bad

Mesotherapy has been hailed as a breakthrough in cosmetic procedures using lipodissolve to eliminate unwanted fat and cellulite. But even though this type of treatment is non-surgical, there is still a price: several – sometimes hundreds – of painful needle injections into the affected areas of the skin. (PRWEB) February 20, 2008 — AA Advanced […]

How to Win Back Patients you’ve Lost

You may be sitting on a gold mine and don’t even know it. I guarantee you have long-long patients in your practice who would return to you if given a chance. If you have been in practice for even a short time, you have developed an eclectic database of various types of patients who:  currently […]

What Your Personal Brand Says About You

Have you thought of yourself as the “Top Doc” to the stars? Or the best anti-aging physician of all time? Or even the best cosmetic dermatologist in your hometown? Is that how your patients see you as well? If not, you need to build a more cohesive image using branding. Branding is the art of […]

Allergan Clarifies FDA’s Inquiry Relates Primarily to High Dose Medical Uses of BOTOX

RVINE, Calif., Feb 08, 2008 (BUSINESS WIRE) — Allergan, Inc. (NYSE:AGN) today commented on and provided support for the U.S. Food and Drug Administration’s (FDA) “Early Communication” regarding a safety review of botulinum toxins in the United States.BOTOX(R) (botulinum toxin type A) is indicated and used to treat a variety of often serious medical conditions, […]

Early Communication about an Ongoing Safety Review Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)

This information reflects FDA’s current analysis of available data concerning these drugs. Posting this information does not mean that FDA has concluded there is a causal relationship between the drug products and the emerging safety issue. Nor does it mean that FDA is advising healthcare professionals to discontinue prescribing these products. FDA is considering, but […]